Features April 2007 Issue

Gene Therapy for Arterial Disease: Is it hype or is There Hope?

New and promising treatments were on the map several years ago, but clinical applications so far have proven elusive.

Optimistism among physicians about potentially revolutionary treatments for arterial disease grew at the turn of the 21st century. Much attention was focused on the theory that angiogenesis (growth of new blood vessels) could be stimulated via gene therapy (inserting genes into cells), thereby increasing blood flow in diseased areas and improving conditions such as coronary artery disease (CAD) and peripheral arterial disease (PAD).

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.